This is an archive article published on August 27, 2020

Phase II of clinical trials: Former CEO of pharma firm, his family among six to receive Covishield dose

"Four volunteers received the Covishield dose after their RT-PCR and antibody tests came out negative for the novel coronavirus,” said Dr Sanjay Lalwani, medical director of Bharati hospital.

Coronavirus vaccine, Coronavirus vaccine price, covid vaccine, covid vaccine price in India, Coronavirus, Covid-19, Covishield, Serum, Serum Institute of India,Oxford, AstraZeneca, Indian ExpressIn India, Covishield is being administered to around 1,600 participants as two full doses 28 days apart, said a senior government official privy to the design of SII’s phase 2/3 clinical trial.

Six people, including a former CEO of a pharmaceutical firm and his family, were administered a dose of the Oxford-AstraZeneca Covid-19 vaccine candidate on Thursday. Four volunteers got the shot at Bharati hospital’s clinical trial site, while two others were injected at KEM hospital and research centre’s clinical trial site at Vadu.

“Four volunteers received the Covishield dose after their RT-PCR and antibody tests came out negative for the novel coronavirus,” said Dr Sanjay Lalwani, medical director of Bharati hospital.

READ | Phase 2 human trial for Covid vaccine begins, 6 people to get first dose today

On Wednesday, two male volunteers became the first to be administered the dose at Bharati hospital, as Phases II and III of the clinical trials of the Oxford-AstraZeneca Covid-19 vaccine candidate began in the country. Known as Covishield, the dose was administered to a 32-year-old man employed at a private firm in the city and a 48-year-old gynaecologist.

READ |  Moderna vaccine promises to be equally effective in older patients

Dr Lalwani said among the four volunteers who received the dose on Thursday, three were women and one a man. Among other volunteers included the daughter of the gynaecologist. In Pune, so far, Bharati hospital and KEM hospital and research centre have commenced with Phase II of the clinical trials and authorities said they would enroll 25 volunteers each within two to three days.


 

Advertisement
Loading Recommendations...
Advertisement
Advertisement
Latest Comment
Post Comment
Read Comments